Molecular basis for gating of cardiac ryanodine receptor: underlying mechanisms for gain- and loss-of function mutations
暂无分享,去创建一个
M. Kikkawa | H. Ogawa | A. Tsutsumi | Kei Saito | T. Murayama | Takuya Kobayashi | T. Sakurai | M. Kodama | N. Kurebayashi | Takashi Sakurai
[1] F. van Petegem,et al. Pathological conformations of disease mutant Ryanodine Receptors revealed by cryo-EM , 2021, Nature Communications.
[2] F. van Petegem,et al. Structural basis for diamide modulation of ryanodine receptor , 2020, Nature Chemical Biology.
[3] M. Samsó,et al. Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM. , 2020, Science advances.
[4] H. Ogawa,et al. Regulatory mechanisms of ryanodine receptor/Ca2+ release channel revealed by recent advancements in structural studies , 2020, Journal of Muscle Research and Cell Motility.
[5] M. Horie,et al. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation. , 2019, Circulation journal : official journal of the Japanese Circulation Society.
[6] Qiang Zhou,et al. Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators , 2019, Proceedings of the National Academy of Sciences.
[7] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[8] F. van Petegem,et al. Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry , 2018, PloS one.
[9] N. Dokholyan,et al. Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel , 2018, The Journal of Biological Chemistry.
[10] M. Horie,et al. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 - Modified Schwartz Score. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[11] M. Horie,et al. A tryptophan residue in the caffeine-binding site of the ryanodine receptor regulates Ca2+ sensitivity , 2018, Communications Biology.
[12] M. Iino,et al. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels , 2018, Molecular Pharmacology.
[13] A. Pérez-Riera,et al. Catecholaminergic polymorphic ventricular tachycardia, an update , 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[14] G. Meissner. The structural basis of ryanodine receptor ion channel function , 2017, The Journal of general physiology.
[15] A. Marks,et al. Ca2+ Release Channels Join the 'Resolution Revolution'. , 2017, Trends in biochemical sciences.
[16] M. Horie,et al. Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity , 2017, The Journal of general physiology.
[17] Jianping Wu,et al. Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2 , 2016, Science.
[18] J. Frank,et al. Structural Basis for Gating and Activation of RyR1 , 2016, Cell.
[19] M. Iino,et al. Genotype–Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel , 2016, Human mutation.
[20] A. J. Williams,et al. Structural insights into Ca2+-activated long-range allosteric channel gating of RyR1 , 2016, Cell Research.
[21] W. Hendrickson,et al. Structures of the colossal RyR1 calcium release channel. , 2016, Current opinion in structural biology.
[22] X. Bai,et al. The Central domain of RyR1 is the transducer for long-range allosteric gating of channel opening , 2016, Cell Research.
[23] M. Samsó,et al. Ultrastructural Analysis of Self-Associated RyR2s. , 2016, Biophysical journal.
[24] N. Grigorieff,et al. CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.
[25] Toshihiro Tanaka,et al. Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes , 2015, PloS one.
[26] Yigong Shi,et al. Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution , 2014, Nature.
[27] M. Horie,et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] E. Behr,et al. Cardiac Evaluation of Pediatric Relatives in Sudden Arrhythmic Death Syndrome: A 2-Center Experience , 2014, Circulation. Arrhythmia and electrophysiology.
[29] A. Bollmann,et al. Ryanodine Receptor Mutations Presenting as Idiopathic Ventricular Fibrillation: A Report on Two Novel Familial Compound Mutations, c.6224T>C and c.13781A>G, With the Clinical Presentation of Idiopathic Ventricular Fibrillation , 2014, Pediatric Cardiology.
[30] Masamichi Ohkura,et al. Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA , 2014, Nature Communications.
[31] Yingying Tang,et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. , 2014, Forensic science international.
[32] K. Aonuma,et al. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[33] A. Karch,et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2013, Neurology.
[34] Paul D. Adams,et al. Use of knowledge-based restraints in phenix.refine to improve macromolecular refinement at low resolution , 2012, Acta crystallographica. Section D, Biological crystallography.
[35] Yongxin Zhao,et al. An Expanded Palette of Genetically Encoded Ca2+ Indicators , 2011, Science.
[36] Silvia G Priori,et al. Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. , 2011, Circulation research.
[37] Michael J Ackerman,et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. , 2009, Journal of the American College of Cardiology.
[38] M. Endo. Calcium-induced calcium release in skeletal muscle. , 2009, Physiological reviews.
[39] Karen N. Allen,et al. research papers Acta Crystallographica Section D Biological , 2003 .
[40] D. Jiang,et al. Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death , 2007, Proceedings of the National Academy of Sciences.
[41] Y. Hayashi,et al. Malignant Hyperthermia in Japan: Mutation Screening of the Entire Ryanodine Receptor Type 1 Gene Coding Region by Direct Sequencing , 2006, Anesthesiology.
[42] I. Nonaka,et al. 0261 Central core disease is due to RyR1 mutations in more than 90% of patients , 2005, Journal of the Neurological Sciences.
[43] David N Mastronarde,et al. Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.
[44] D. Tester,et al. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. , 2004, Mayo Clinic proceedings.
[45] D. Tester,et al. Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes , 2004, Circulation.
[46] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[47] Emily F. Farrell,et al. Ryanodine receptor channelopathies. , 2004, Biochemical and biophysical research communications.
[48] D. Bers. Macromolecular complexes regulating cardiac ryanodine receptor function. , 2004, Journal of molecular and cellular cardiology.
[49] G. Danieli,et al. Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias. , 2004, Clinical chemistry.
[50] Carlo Napolitano,et al. Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.
[51] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[52] B. Wallace,et al. The pore dimensions of gramicidin A. , 1993, Biophysical journal.
[53] A. Fabiato,et al. CALCIUM‐INDUCED RELEASE OF CALCIUM FROM THE SARCOPLASMIC RETICULUM OF SKINNED CELLS FROM ADULT HUMAN, DOG, CAT, RABBIT, RAT, AND FROG HEARTS AND FROM FETAL AND NEW‐BORN RAT VENTRICLES * , 1978, Annals of the New York Academy of Sciences.
[54] S. Eletr,et al. Phospholipid orientation in sarcoplasmic membranes: spin-label ESR and proton MNR studies. , 1972, Biochimica et biophysica acta.
[55] A. Leenhardt,et al. Catecholaminergic Polymorphic Ventricular , 2020, Clinical Cardiogenetics.
[56] N. Yan,et al. Modulation of cardiac ryanodine receptor 2 by calmodulin , 2019, Nature.
[57] J. Frank,et al. Ryanodine Receptor Structure and Function in Health and Disease. , 2018, Sub-cellular biochemistry.
[58] M. Horie,et al. A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia. , 2017, Heart rhythm.
[59] Y. Ogawa. Role of ryanodine receptors. , 1994, Critical reviews in biochemistry and molecular biology.
[60] G. Meissner,et al. Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. , 1994, Annual review of physiology.
[61] B. Surawicz. Ventricular fibrillation. , 1971, The American journal of cardiology.